Free Trial

Envista (NVST) Competitors

Envista logo
$18.70 +0.67 (+3.72%)
(As of 12/20/2024 05:31 PM ET)

NVST vs. SOLV, SNN, PEN, GKOS, BLCO, INSP, PRCT, AXNX, NVCR, and NARI

Should you be buying Envista stock or one of its competitors? The main competitors of Envista include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Axonics (AXNX), NovoCure (NVCR), and Inari Medical (NARI). These companies are all part of the "medical equipment" industry.

Envista vs.

Solventum (NYSE:SOLV) and Envista (NYSE:NVST) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation.

Solventum presently has a consensus target price of $68.29, indicating a potential upside of 2.18%. Envista has a consensus target price of $20.65, indicating a potential upside of 10.45%. Given Envista's stronger consensus rating and higher possible upside, analysts clearly believe Envista is more favorable than Solventum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solventum
1 Sell rating(s)
9 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Envista
2 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.06

Solventum has a net margin of 0.00% compared to Envista's net margin of -53.42%. Envista's return on equity of 3.76% beat Solventum's return on equity.

Company Net Margins Return on Equity Return on Assets
SolventumN/A N/A N/A
Envista -53.42%3.76%2.24%

In the previous week, Solventum had 13 more articles in the media than Envista. MarketBeat recorded 14 mentions for Solventum and 1 mentions for Envista. Solventum's average media sentiment score of 1.24 beat Envista's score of 0.63 indicating that Solventum is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Solventum
10 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Envista
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Solventum has higher revenue and earnings than Envista.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Solventum$8.26B1.40N/AN/AN/A
Envista$2.50B1.29-$100.20M-$7.77-2.41

Envista received 33 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 37.78% of users gave Envista an outperform vote while only 5.56% of users gave Solventum an outperform vote.

CompanyUnderperformOutperform
SolventumOutperform Votes
1
5.56%
Underperform Votes
17
94.44%
EnvistaOutperform Votes
34
37.78%
Underperform Votes
56
62.22%

Summary

Envista beats Solventum on 7 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVST vs. The Competition

MetricEnvistaDental equipment & supplies IndustryMedical SectorNYSE Exchange
Market Cap$3.22B$3.80B$5.12B$19.18B
Dividend YieldN/A1.74%4.91%3.59%
P/E Ratio-2.4136.7891.3441.28
Price / Sales1.291.511,116.5917.59
Price / Cash7.6511.1942.6421.28
Price / Book0.771.054.795.32
Net Income-$100.20M-$33.08M$120.07M$989.88M
7 Day Performance-3.95%-0.60%-1.89%-3.54%
1 Month Performance-12.58%-1.91%11.45%-3.68%
1 Year Performance-23.38%115.25%30.61%12.14%

Envista Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVST
Envista
3.9074 of 5 stars
$18.70
+3.7%
$20.65
+10.4%
-21.1%$3.22B$2.50B-2.4112,800Positive News
High Trading Volume
SOLV
Solventum
1.298 of 5 stars
$69.77
+0.3%
$68.29
-2.1%
N/A$12.05BN/A0.0022,000Positive News
SNN
Smith & Nephew
3.7112 of 5 stars
$25.51
-0.1%
N/A-7.3%$11.15B$5.55B13.0318,452News Coverage
PEN
Penumbra
4.225 of 5 stars
$247.93
+1.0%
$252.42
+1.8%
-1.8%$9.52B$1.16B285.524,200Analyst Forecast
GKOS
Glaukos
4.1194 of 5 stars
$143.83
+3.5%
$143.17
-0.5%
+89.5%$7.93B$360.35M-46.00780Analyst Forecast
Short Interest ↓
BLCO
Bausch + Lomb
3.1618 of 5 stars
$18.56
-0.2%
$20.58
+10.9%
+16.9%$6.54B$4.68B-17.7113,300
INSP
Inspire Medical Systems
4.6583 of 5 stars
$188.59
+0.4%
$233.58
+23.9%
+1.7%$5.65B$755.59M176.781,011Positive News
PRCT
PROCEPT BioRobotics
2.7661 of 5 stars
$89.09
-0.2%
$97.86
+9.8%
+102.9%$4.65B$136.19M0.00626Positive News
AXNX
Axonics
1.4263 of 5 stars
$70.98
+0.8%
$71.00
+0.0%
+20.9%$3.63B$366.38M-591.45610High Trading Volume
NVCR
NovoCure
2.4937 of 5 stars
$32.75
-2.0%
$32.67
-0.3%
+138.4%$3.54B$577.74M-23.861,453
NARI
Inari Medical
3.3112 of 5 stars
$55.12
-0.8%
$58.89
+6.8%
-11.9%$3.23B$574.50M-41.181,300Analyst Forecast
Insider Trade

Related Companies and Tools


This page (NYSE:NVST) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners